
After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’
When it comes to advisory committee meetings—such as that of next week’s Oncologic Drugs Advisory Committee—the FDA is operating with a “fake it till you make it,” mentality, an agency insider told BioSpace. The massive workforce cuts that have hit the FDA …